Skip to main content
TipRanks
Go Ultimate75% OFF

MyHealthChecked PLC (0I10) Stock Price & Analysis

0 Followers

0I10 Stock Chart & Stats

€0.08€0.00(0.00%)
At close: 5:30 PM GMT+1
€0.11€0.115€0.12€0.125Feb 9Mar 10Mar 18Apr 20Apr 27
Day’s Range
EUR 0.08 - EUR 0.08
52-Week Range
EUR 0.07 - EUR 0.13
Previous Close
EUR 0.08
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 3.16M
Enterprise Value
EUR 258.04K
Total Cash (Recent Filing)
EUR 3.48M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
0.96
Next Earnings
Jun 08, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Very low leverage reduces interest burden and refinancing exposure, preserving financial flexibility if operations recover. The still-positive equity base gives the company some capacity to fund a restructuring or reinvestment plan without the immediate pressure of substantial debt obligations.

Proven Profitability

Earlier profitability shows that the company has previously demonstrated an ability to convert its diagnostics activities into earnings. This history provides evidence of potential operating-model viability, although restoring sufficient revenue and margins remains essential for that capability to become relevant again.

Improved Cash Burn

The year-over-year improvement in free cash flow indicates that cash consumption moderated, which can extend financial runway while management works to rebuild the business. This is only a supporting positive because cash flow remained negative and the company still needs an operating recovery.

Bears Say

Revenue Collapse

The prolonged revenue contraction signals a severe loss of commercial activity and customer demand, rather than a single weak reporting period. Revenue at effectively zero leaves little operating scale, weakens the platform for fixed-cost absorption, and makes near-term recovery dependent on rebuilding sales.

Persistent Unprofitability

Recent losses and negative gross profit show that the company is not currently covering the economics of its activities through revenue. Continued negative margins can accelerate equity erosion, constrain investment in products and services, and make a return to sustainable profitability more difficult.

Ongoing Cash Burn

Sustained negative operating and free cash flow means the business is consuming resources rather than funding itself internally. Even with lower burn in 2025, continued cash outflows can reduce resilience and increase reliance on existing reserves or future financing until revenue and margins recover.

MyHealthChecked PLC News

0I10 FAQ

What was MyHealthChecked PLC’s price range in the past 12 months?
MyHealthChecked PLC lowest stock price was €0.07 and its highest was €0.13 in the past 12 months.
What is MyHealthChecked PLC’s market cap?
MyHealthChecked PLC’s market cap is €3.16M.
When is MyHealthChecked PLC’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MyHealthChecked PLC’s earnings last quarter?
MyHealthChecked PLC released its earnings results on Sep 15, 2026. The company reported -€0.004 earnings per share for the quarter.
Is MyHealthChecked PLC overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MyHealthChecked PLC pay dividends?
MyHealthChecked PLC does not currently pay dividends.
What is MyHealthChecked PLC’s EPS estimate?
MyHealthChecked PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MyHealthChecked PLC have?
MyHealthChecked PLC has 32,451,977 shares outstanding.
What happened to MyHealthChecked PLC’s price movement after its last earnings report?
MyHealthChecked PLC reported an EPS of -€0.004 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MyHealthChecked PLC?
Currently, no hedge funds are holding shares in DE:0I10
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology